Our protocol goes far beyond the script, combining unlimited access to expert providers, personalized nutrition support, app-based tracking, and a connected patient community. In a retrospective analysis of 1,131 patients treated with the GLP-1 drug semaglutide, combined with individualized medical oversight, patients lost an average of 45.9 pounds (19.5% total body weight loss) at 52 weeks, with those extending to 68 weeks achieving an average total weight loss of 46.9 pounds (21.8%)
GLP-1: physiological effects and potential therapeutic applications
Some patients taking tirzepatide (Mounjaro, Zepbound) report experiencing taste changes, including metallic or altered taste sensations
Temporarily Continue Compounded Versions (if available) Some 503B pharmacies may still legally compound using finished FDA-approved drug products
Please Note : Do Not buy or accept any product if seal is broken Beast Nutrition sources products directly from brands or official importers